TLR9 and candidiasis: The lower secretion of IgM and IgG in patients during the study might be due to the abnormal transmission of the TLR9-STAT3 signal pathway, which weakened the immune response, slowed the secretion of antibodies, shifted the peak of antibody secretion, then led to patients' repeated Candida infection.